Andras Borsi
6PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Apr 06, 2021
A nationwide real-world study on dynamic ustekinumab dosing and concomitant medication use among Crohn's disease patients in Finland.Taina Sipponen, Clas-Göran Af Björkesten, Taru Hallinen
|Mar 19, 2021
Increased use of biologics in the era of TNF-α inhibitors did not reduce surgical rate but prolonged the time from diagnosis to first time intestinal resection among patients with Crohn's disease and ulcerative colitis - a Danish register-based study from 2003-2016.Niels Qvist, Kasper Vadstrup, Sarah Alulis
|Mar 03, 2020
Treatment patterns for biologics in ulcerative colitis and Crohn's disease: a Danish Nationwide Register Study from 2003 to 2015.Sarah Alulis, Kasper Vadstrup, Andras Borsi
|Jan 25, 2020
Epidemiological data and utilization patterns of anti-TNF alpha therapy in the Hungarian ulcerative colitis population between 2012-2016.Péter Kunovszki, Kata Judit Szántó, Judit Gimesi-Országh
|Jan 22, 2020
Societal costs attributable to Crohn's disease and ulcerative colitis within the first 5 years after diagnosis: a Danish nationwide cost-of-illness study 2002-2016.Kasper Vadstrup, Sarah Alulis, Andras Borsi
|Jun 14, 2019
Dose escalation and switching of biologics in ulcerative colitis: a systematic literature review in real-world evidence.Nathalie C Gemayel, Eugenio Rizzello, Petar Atanasov
Pageof 1
Frequent Collaborators
1 joint publications
Nathalie C Gemayel
1 joint publications
Daniel Wirth
1 joint publications
Kata Judit Szántó
1 joint publications
Anita Bálint
1 joint publications
Klaudia Farkas
1 joint publications
Ágnes Milassin
1 joint publications
Tamás Molnár
1 joint publications
Pia Munkholm
1 joint publications
Taina Sipponen
